Print

Curis, Inc. (CRIS) to Present at Upcoming Health Care and Investor Conferences  
8/30/2012 9:23:52 AM

LEXINGTON, Mass., Aug. 30, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will present at the following upcoming conferences:
//-->